Ruxolitinib in children with steroid | 合法藥品大搜索
由LLaisne著作·2020—Ruxolitinibinchildrenwithsteroid-refractoryacutegraft-versus-hostdisease:AretrospectivemulticenterstudyofthepediatricgroupofSFGM-TC·Authors.
由 L Laisne 著作 · 2020 — Ruxolitinib in children with steroid-refractory acute graft-versus-host disease: A retrospective multicenter study of the pediatric group of SFGM-TC · Authors.
ruxolitinib pediatric ruxolitinib pediatric 高血壓藥是抗凝血藥嗎 腹膜透析脫水量減少 福善美致癌 脂佳膠囊 dgl副作用 立舒定功效 立舒定ptt 金 壕 鼻炎軟膠囊 評價
Ruxolitinib in children with steroid‐refractory acute graft ... | 合法藥品大搜索
由 L Laisne 著作 · 2020 — Ruxolitinib may constitute a promising second-line treatment for children with steroid-refractory aGVHD that should be validated in a prospective ... Read More
Ruxolitinib salvage therapy is effective for steroid‐refractory ... | 合法藥品大搜索
由 V Uygun 著作 · 2020 · 被引用 3 次 — This study aimed to evaluate the efficacy of ruxolitinib in 29 children with steroid-refractory acute or chronic GVHD. Twenty-five (87%) patients ... Read More
Ruxolitinib as Salvage Therapy in Steroid ... | 合法藥品大搜索
由 P Khandelwal 著作 · 2017 · 被引用 65 次 — We describe our retrospective clinical experience with ruxolitinib for steroid-refractory acute graft-versus-host disease (GVHD) in pediatric allogeneic ... Read More
Ruxolitinib treatment for steroid refractory acute and chronic ... | 合法藥品大搜索
由 MG Vicent 著作 · 2019 · 被引用 39 次 — We analyzed clinical and immunological changes in children with GvHD taking ruxolitinib. Twenty-two children that underwent transplantation and received ... Read More
Ruxolitinib in children with steroid | 合法藥品大搜索
由 L Laisne 著作 · 2020 — Ruxolitinib in children with steroid-refractory acute graft-versus-host disease: A retrospective multicenter study of the pediatric group of SFGM-TC · Authors. Read More
Ruxolitinib for steroid | 合法藥品大搜索
由 Y Mozo 著作 · 2021 — In this retrospective study, we evaluated the outcomes of 19 children who received ruxolitinib for refractory acute or chronic GvHD (cGvHD) after ... Read More
Ruxolitinib as Salvage Therapy in Steroid | 合法藥品大搜索
由 P Khandelwal 著作 · 2017 · 被引用 65 次 — Pediatric dosing of ruxolitinib in acute GVHD is unknown. Doses of 50 mg/m2 twice daily have been used in pediatric patients treated for refractory leukemia [9]. Read More
Ruxolitinib Is Promising in Pediatric Chronic GVHD | 合法藥品大搜索
2021年2月11日 — The FDA approved ruxolitinib for the treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years and older in 2019 ... Read More
相關資訊整理
【捷可衛錠 20毫克】1.適用於治療中度風險或高風險之骨髓纖維化,包括原發性骨髓纖維化、真性紅血球增多症後骨髓纖維化、或血小板增多症後骨髓纖維化。2.適用於接受hydroxyurea 治療後有抗藥性或無耐受性的真性紅血球增多症。
藥品名稱:捷可衛錠20毫克許可證字號:衛部藥輸字第026361號許可證種類:製 劑適應症:1.適用於治療中度風險或高風險之骨髓纖維...
【捷可衛錠 10毫克】1.適用於治療中度風險或高風險之骨髓纖維化,包括原發性骨髓纖維化、真性紅血球增多症後骨髓纖維化、或血小板增多症後骨髓纖維化。2.適用於接受hydroxyurea 治療後有抗藥性或無耐受性的真性紅血球增多症。
藥品名稱:捷可衛錠10毫克許可證字號:衛部藥輸字第026707號許可證種類:製 劑適應症:1.適用於治療中度風險或高風險之骨髓纖維...
【捷可衛錠 5毫克】1.適用於治療中度風險或高風險之骨髓纖維化,包括原發性骨髓纖維化、真性紅血球增多症後骨髓纖維化、或血小板增多症後骨髓纖維化。2.適用於接受hydroxyurea 治療後有抗藥性或無耐受性的真性紅血球增多症。
藥品名稱:捷可衛錠5毫克許可證字號:衛部藥輸字第026359號許可證種類:製 劑適應症:1.適用於治療中度風險或高風險之骨髓纖維...
【捷可衛錠 15毫克】1.適用於治療中度風險或高風險之骨髓纖維化,包括原發性骨髓纖維化、真性紅血球增多症後骨髓纖維化、或血小板增多症後骨髓纖維化。2.適用於接受hydroxyurea 治療後有抗藥性或無耐受性的真性紅血球增多症。
藥品名稱:捷可衛錠15毫克許可證字號:衛部藥輸字第026360號許可證種類:製 劑適應症:1.適用於治療中度風險或高風險之骨髓纖維...